1. Home
  2. CRWS vs TVRD Comparison

CRWS vs TVRD Comparison

Compare CRWS & TVRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Crown Crafts Inc

CRWS

Crown Crafts Inc

HOLD

Current Price

$2.68

Market Cap

29.4M

ML Signal

HOLD

Logo Tvardi Therapeutics Inc.

TVRD

Tvardi Therapeutics Inc.

HOLD

Current Price

$1.91

Market Cap

27.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRWS
TVRD
Founded
1957
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Textiles
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.4M
27.5M
IPO Year
1994
2013

Fundamental Metrics

Financial Performance
Metric
CRWS
TVRD
Price
$2.68
$1.91
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$29.50
AVG Volume (30 Days)
114.6K
128.2K
Earning Date
02-11-2026
05-14-2026
Dividend Yield
11.49%
N/A
EPS Growth
118.89
79.01
EPS
0.17
N/A
Revenue
$70,270,000.00
$911,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$15.88
N/A
Revenue Growth
6.51
959.30
52 Week Low
$2.35
$1.50
52 Week High
$3.14
$43.65

Technical Indicators

Market Signals
Indicator
CRWS
TVRD
Relative Strength Index (RSI) 36.81 43.61
Support Level $2.69 $1.72
Resistance Level $2.91 $2.04
Average True Range (ATR) 0.09 0.09
MACD -0.02 0.04
Stochastic Oscillator 12.16 44.48

Price Performance

Historical Comparison
CRWS
TVRD

About CRWS Crown Crafts Inc

Crown Crafts Inc operates in the infant and toddler products segment of the consumer products industry through its wholly-owned subsidiaries. The infant and toddler products segment consists of infant and toddler bedding, bibs, soft bath products, disposable products, and accessories. The company serves a diverse range of customers including mass merchants, mid-tier retailers, juvenile specialty stores, value channel stores, grocery and drug stores, restaurants, internet accounts, wholesale clubs, and internet-based retailers. The company's brands include NoJo, Neat Solutions, Sassy, and Carousel. Its products are marketed under a variety of company-owned trademarks, under trademarks licensed from others, and as private-label goods.

About TVRD Tvardi Therapeutics Inc.

Tvardi Therapeutics Inca clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting Signal Transducer and Activator of Transcription 3 (STAT3) to treat inflammatory and proliferative diseases with unmet need. Its pipeline includes two oral, small molecule STAT3 inhibitors: TTI-101 and TTI-109. TTI-101 is its first-generation direct STAT3 inhibitor, currently in Phase 1b/2 clinical development in hepatocellular carcinoma (HCC). TTI-109 is a phosphate prodrug of TTI-101 that is mechanistically identical to its parent molecule but is designed to enhance its ability to target STAT3.

Share on Social Networks: